Canada markets open in 8 hours 2 minutes

Nabriva Therapeutics plc (NBRV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.5330-0.0070 (-1.30%)
At close: 4:00PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 576.73M
Enterprise Value 335.8M
Trailing P/E N/A
Forward P/E 1-1.62
PEG Ratio (5 yr expected) 1-0.01
Price/Sales (ttm)9.00
Price/Book (mrq)1.71
Enterprise Value/Revenue 34.20
Enterprise Value/EBITDA 6-0.49

Trading Information

Stock Price History

Beta (5Y Monthly) 2.23
52-Week Change 3-71.50%
S&P500 52-Week Change 315.51%
52 Week High 32.2300
52 Week Low 30.4850
50-Day Moving Average 30.5936
200-Day Moving Average 30.6620

Share Statistics

Avg Vol (3 month) 34.93M
Avg Vol (10 day) 31.31M
Shares Outstanding 5143.96M
Float 142.04M
% Held by Insiders 11.23%
% Held by Institutions 143.41%
Shares Short (Sep. 14, 2020) 47.48M
Short Ratio (Sep. 14, 2020) 44.18
Short % of Float (Sep. 14, 2020) 45.23%
Short % of Shares Outstanding (Sep. 14, 2020) 45.20%
Shares Short (prior month Aug. 13, 2020) 49.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 210:1
Last Split Date 3Jun. 25, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-866.57%

Management Effectiveness

Return on Assets (ttm)-62.13%
Return on Equity (ttm)-181.05%

Income Statement

Revenue (ttm)8.53M
Revenue Per Share (ttm)0.09
Quarterly Revenue Growth (yoy)-7.20%
Gross Profit (ttm)-17M
EBITDA -73.55M
Net Income Avi to Common (ttm)-79.54M
Diluted EPS (ttm)-0.8770
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.84M
Total Cash Per Share (mrq)0.35
Total Debt (mrq)8.97M
Total Debt/Equity (mrq)20.19
Current Ratio (mrq)5.68
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-75.59M
Levered Free Cash Flow (ttm)-47.95M